NewEdge Wealth’s ContraFect Corporation CFRX Stock Holding History

NewEdge Wealth’s Portfolio CFRX Stock Details CFRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-250	Closed	-$1.92K	–	647
2022 Q4	$1.92K	Buy	+250	New	+$2.89K	﹤0.01%	542

Other funds holding CFRX

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

BAM

Belpointe Asset Management Reno, Nevada $2.74B AUM 20.71% 1-Year Est. Return

NewEdge Wealth's CFRX Position: Q1 2023 in Review

NewEdge Wealth sold out of ContraFect Corporation (CFRX) in Q1 2023, closing a stake of 250 shares — an estimated $1.92K sold.

NewEdge Wealth first reported a position in CFRX in Q4 2022 and held it in 1 quarter. The position peaked at $1.92K in Q4 2022. 19 funds tracked by Wall St. Rank hold CFRX as of Q1 2023.

NewEdge Wealth reported no remaining ContraFect Corporation position as of Q1 2023 after selling out during the quarter.
NewEdge Wealth sold 250 ContraFect Corporation shares in Q1 2023, an estimated $1.92K.
NewEdge Wealth first reported a position in ContraFect Corporation in Q4 2022 and held it in 1 quarter.
NewEdge Wealth's ContraFect Corporation position peaked at $1.92K in Q4 2022.
19 funds tracked by Wall St. Rank held ContraFect Corporation as of Q1 2023.

Based on NewEdge Wealth's 13F filing for Q1 2023, filed 8 May 2023.